GENE ONLINE|News &
Opinion
Blog

HIV
Trials & Approvals HIV
Merck’s Phase 2 HIV Treatment Study Resumes with Phase 3 Program Announcement
2022-09-20
Special HIV
A Cure for HIV Could Be Here Sooner Than You Think – Future of Health
2022-09-16
Trials & Approvals HIV
Gilead’s Novel Capsid Inhibitor Treatment for HIV Gains First Approval from European Commission
2022-08-22
Innovation HIVAIDST-cells
HIV Latent Cells Could Lead to Possible Cure
2022-07-28
Trials & Approvals PD-L1
Ascletis Begins Study of PD-L1 Antibody Candidate Against HIV
2022-07-04
Technology AIDS
This One-Time Injection Could Cure AIDS
2022-06-21
Trials & Approvals AIDS
FDA Allows Resumption of Gilead’s Lenacapavir AIDS Trials
2022-05-19
Ranking & Reports
GeneOnline’s Top 10 Editor’s Picks for 2021
2021-12-23
Trials & Approvals HIV
FDA Approves First Injectable Treatment for HIV Pre-Exposure Prevention
2021-12-22
Innovation HIV
Experimental mRNA Vaccine Could Lead Fight Against HIV
2021-12-19
Innovation Digital HealthcareHIV
A Digital Solution Tracks Pill Adherence with 98% Accuracy
2021-12-13
Asia-Pacific CDMO
Samsung Biologics Inks CDMO Deal with Enzolytics on HIV and COVID-19 Antibodies
2021-10-08
Trials & Approvals HIV
J&J’s HIV Vaccine Results Disappoint, Trial Halted But Search Continues
2021-09-01
R&D HIV
Gilead, Merck Unite to Contest ViiV’s Cabenuva with Long-Acting HIV Therapy
2021-03-16
Trials & Approvals HIV
Gilead Reports FDA-Approved HIV Therapy Demonstrates Long-Term Efficacy
2021-03-11
1 2
LATEST
AstraZeneca Welcomes Neurofibromatosis And Asthma Treatment Approvals in Japan
2022-09-28
GO PRIME
Biogen Concludes $900 Million Settlement Before Posting Positive Data From Alzheimer’s Trial
2022-09-28
Arsenal Biosciences Announced Another $70 million Collaboration, This Time With Genentech
2022-09-27
Sciwind Biosciences And SynerK Join Forces To Develop siRNA Therapeutics
2022-09-27
Acticor Enrolls First Patient in Phase 2/3 Stroke Treatment Study
2022-09-27
Daiichi Sankyo Wins Approval For Cancer Treatment in Japan
2022-09-26
Seagen Strikes Potential $650 million Deal with LAVA Therapeutics for Cancer Treatment
2022-09-26
READ MORE
EVENT
2022-10-12
BioJapan / Regenerative Medicine Japan / healthTECH JAPAN 2022
Japan
2022-10-26
Brussels, Belgium – EFIB 2022
Brussels, Belgium
2022-11-07
2nd World Congress on Primary Healthcare and Medicare Summit
Paris, France
2022-11-07
BioFuture | Beyond Disruption: The New Age of Healthcare and Technology
New York city
2022-11-14
MEDICA2022
Germany
2022-12-10
64TH ASH ANNUAL MEETING & EXPOSITION
New Orleans, Louisiana
SEE MORE
Newsletter
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2022 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top

Enjoy Your First 14 Days for $1.49

SUBSCRIBE NOW

Create an account with us now to say goodbye to all the pop-ups!